Bringing Web3 to medical research
Triall offers innovative software for clinical trials. Since 2018, Triall has been spearheading the implementation of decentralised & privacy-enhancing technologies in clinical research, working together with expert organisations such as Mayo Clinic and innovating on top of a platform that has been used in over 8,000 clinical trials worldwide. Powered by its utility token $TRL, Triall is gradually building towards the Clinical Insights Exchange (CIX), a federated data ecosystem that offers a platform for advanced analytics and AI while facilitating fair data exchange between researchers, patients, and other key stakeholders.
TRL in the Triall ecosystem
TRL Platform Fee
TRL provides access to the Triall platform where it is used to purchase software and services for each new clinical trial.
Lock-up Mechanism
65% of the TRL Platform Fee is locked for the entire duration of the clinical trial.
Burn Mechanism
17.5% of the TRL Platform Fee is permanently burned from the token supply.
Liquidity Boost
The remaining 17.5% is doubled with the reserves of the TRL Treasury and used to increase the liquidity depth of the TRL token market.
TRL is intended for
Rewards and incentives
For patients and investigator communities. Promoting clinical trial recruitment, retention, and engagement—major issues in the current clinical trial environment.
Monetisation of data assets
Enabling fractional data ownership between Sponsor, CROs, Investigative Sites, and patients.
Payments & Reimbursements
Direct, milestone-based payments and reimbursement, facilitated through programmable contracts and workflows.
TRL is tradable on the following exchanges
Need help? We prepared several guides to help you on your way.
TRL is used in the real world today
Last updated: Wed 29 Nov, 2023
Spearheading Web3 technology in clinical trials
First Mover
World’s first to implement blockchain in live and running clinical trials with our successful pilot in 2019.
Industry Experience
Deep understanding of industry needs and trends. Team managed 150+ clinical trials across 30+ countries.
Global Network
Value network of industry partners and potential customers that stretches the globe.
Thought Leader
Published blockchain article in Science and 250+ peer-reviewed papers on innovation in the Life Sciences.
Market Validation
Collaborating with industry-leading stakeholders in our customer domain to build our future vision.
Double-Digit Market
The market for clinical trial software (‘eClinical solutions’) is growing at a CAGR of 13.8%.
Meet the people behind Triall
Combined, our team has managed 150+ clinical trials across 30+ countries, published about clinical research and innovation in top-tier academic journals such as Nature Biotechnology and Science, and successfully developed companies through all stages of growth, both in the Life Sciences and in the enterprise software domain.
Join Us
Our articles on Medium
We regularly publish articles about the TRL project on Medium. You may find a selection below.
View all
Triall joins the Dutch Blockchain Coalition
Initiating the improved TRL Token Economics: new study onboarded
Triall Roadmap Update